STERIALS

A biopharmaceutical company focused on developing new cancer-specific drugs. The company is focused on developing novel anti-cancer drugs that inhibit key signaling pathways that drive cancer cell survival and tumor growth, and is developing treatments for a variety of solid cancers, including low-grade serous ovarian cancer, non-small cell lung cancer, colorectal cancer, and pancreatic cancer. The company is based in Delaware.